The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
On Thursday, the Food and Drug Administration approved the non-opioid pain relievers from Vertex Pharmaceuticals, a new ...
HOUSTON, Mo. — The Houston R-1 School District announced today it will be closed on Friday due to a high number of students ...
Leaders of the Michigan Innocence Clinic and exonerees were mourning after learning that an attorney whose work helped clear ...